(Q34013059)

English

Validation of tumor-associated macrophage ferritin light chain as a prognostic biomarker in node-negative breast cancer tumors: A multicentric 2004 national PHRC study

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Validation of tumor-associated macrophage ferritin light chain as a prognostic biomarker in node-negative breast cancer tumors: A multicentric 2004 national PHRC study (English)

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

0 references

1 reference

based on heuristic

inferred from title

2

object named as

Loïc Campion

0 references

Pascal Jézéquel

1

object named as

Pascal Jézéquel

0 references

Catherine Guérin-Charbonnel

6

object named as

Catherine Guérin-Charbonnel

0 references

Delphine Loussouarn

4

object named as

Delphine Loussouarn

0 references

author name string

Frédérique Spyratos

3

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Mario Campone

5

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Marie-Pierre Joalland

7

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Jean André

8

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Françoise Descotes

9

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Catherine Grenot

10

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Pascal Roy

11

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Antoine Carlioz

12

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Pierre-Marie Martin

13

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Agnès Chassevent

14

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Marie-Lise Jourdan

15

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Gabriel Ricolleau

16

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

language of work or name

0 references

publication date

20 October 2011

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

International Journal of Cancer

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

131

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

426-437

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Meeting highlights: updated international expert consensus on the primary therapy of early breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26397

21 January 2018

A gene-expression signature as a predictor of survival in breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26397

21 January 2018

Pharmacoproteomic analysis of prechemotherapy and postchemotherapy plasma samples from patients receiving neoadjuvant or adjuvant chemotherapy for breast carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26397

21 January 2018

Proteomic patterns of nipple aspirate fluids obtained by SELDI-TOF: potential for new biomarkers to aid in the diagnosis of breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26397

21 January 2018

Proteomic analysis of nipple aspirate fluid using SELDI-TOF-MS.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26397

21 January 2018

Proteomic profiling of primary breast cancer predicts axillary lymph node metastasis.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26397

21 January 2018

Surface-enhanced laser desorption/ionization time of flight mass spectrometry protein profiling identifies ubiquitin and ferritin light chain as prognostic biomarkers in node-negative breast cancer tumors

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26397

21 January 2018

Epithelial-mesenchymal transition: a cancer researcher's conceptual friend and foe.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26397

21 January 2018

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26397

21 January 2018

Validation of UBE2C protein as a prognostic marker in node-positive breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26397

21 January 2018

Distribution of ferritin, transferrin and lactoferrin in breast carcinoma tissue

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26397

21 January 2018

Tissue ferritin concentration and prognosis in carcinoma of the breast

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26397

21 January 2018

Regulation of ferritin genes and protein

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26397

21 January 2018

Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: potential targets of anti-cancer therapy

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26397

21 January 2018

Polarization dictates iron handling by inflammatory and alternatively activated macrophages

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26397

21 January 2018

Understanding the molecular basis of histologic grade

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26397

21 January 2018

Analysis of the biologic functions of H- and L-ferritins in HeLa cells by transfection with siRNAs and cDNAs: evidence for a proliferative role of L-ferritin

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26397

21 January 2018

Proteomic analysis identifies candidate proteins associated with distant recurrences in breast cancer after adjuvant chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26397

21 January 2018

Role of ferritin alterations in human breast cancer cells

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26397

21 January 2018

Cancer-related inflammation

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26397

21 January 2018

Macrophages define the invasive microenvironment in breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26397

21 January 2018

Macrophage diversity enhances tumor progression and metastasis

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26397

21 January 2018

The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26397

21 January 2018

Macrophage activation increases the invasive properties of hepatoma cells by destabilization of the adherens junction.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26397

21 January 2018

Differential regulation of iron homeostasis during human macrophage polarized activation.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26397

21 January 2018

Role of iron in estrogen-induced cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26397

21 January 2018

Does excess iron play a role in breast carcinogenesis? An unresolved hypothesis

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26397

21 January 2018

Does iron have a role in breast cancer?

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26397

21 January 2018

Ferroportin and Iron Regulation in Breast Cancer Progression and Prognosis

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26397

21 January 2018

Regulatory effects of ferritin on angiogenesis

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26397

21 January 2018

Iron chelators with high antiproliferative activity up-regulate the expression of a growth inhibitory and metastasis suppressor gene: a link between iron metabolism and proliferation

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26397

21 January 2018

Iron chelation regulates cyclin D1 expression via the proteasome: a link to iron deficiency-mediated growth suppression

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26397

21 January 2018

Cancer cell iron metabolism and the development of potent iron chelators as anti-tumour agents.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26397

21 January 2018

Identifiers

10.1002/IJC.26397

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34013059&oldid=1537537582"